Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Safety, Efficacy and Pharmacokinetics of GreenGene™ F in Previously Treated Patients 12 Years of Age or Older Diagnosed With Severe Hemophilia A

NCT01619046 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT01619046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01619046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Safety, Efficacy and Pharmacokinetics of GreenGene™ F in Previously Treated Patients 12 Years of Age or Older Diagnosed With Severe Hemophilia A
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2013
Completion date
September 30, 2015
Enrollment
124 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a